Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxine Sun

Showing results (221-230 of 401) with videos related to

Pageof 41
Sort By:
BJU International|August 20, 2011
Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trialChristopher E Barbieri, Eugene K Cha, Thomas F Chromecki, et al.
European Urology|August 27, 2011
A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysisMaxine Sun, Firas Abdollah, Marco Bianchi, et al.
BJU International|September 7, 2013
Benefit in regionalisation of care for patients treated with radical cystectomy: a nationwide inpatient sample analysisPraful Ravi, Marco Bianchi, Jens Hansen, et al.
International Journal of Radiation Oncology, Biology, Physics|December 20, 2013
Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapiesAlberto Briganti, Steven Joniau, Giorgio Gandaglia, et al.
The Journal of Urology|January 20, 2010
Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissectionMaxine Sun, Giovanni Lughezzani, Ahmed Alasker, et al.
BJU International|November 15, 2011
Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomyThomas F Chromecki, Eugene K Cha, Karl Pummer, et al.
Cancer|June 22, 2011
Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysisShahrokh F Shariat, Caroline Savage, Thomas F Chromecki, et al.
The Journal of Urology|August 13, 2013
Emergency department visits in the United States for upper urinary tract stones: trends in hospitalization and chargesKhurshid R Ghani, Florian Roghmann, Jesse D Sammon, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 17, 2013
Survival after nephroureterectomy for upper tract urothelial carcinoma: a population-based competing-risks analysisGiorgio Gandaglia, Marco Bianchi, Quoc-Dien Trinh, et al.
Clinical Genitourinary Cancer|December 31, 2014
Cardiovascular mortality in patients with metastatic prostate cancer exposed to androgen deprivation therapy: a population-based studyGiorgio Gandaglia, Maxine Sun, Ioana Popa, et al.
Pageof 41

Showing results (221-230 of 401) with videos related to

Sort By:
Pageof 41
BJU International|August 20, 2011
Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trialChristopher E Barbieri, Eugene K Cha, Thomas F Chromecki, et al.
European Urology|August 27, 2011
A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysisMaxine Sun, Firas Abdollah, Marco Bianchi, et al.
BJU International|September 7, 2013
Benefit in regionalisation of care for patients treated with radical cystectomy: a nationwide inpatient sample analysisPraful Ravi, Marco Bianchi, Jens Hansen, et al.
International Journal of Radiation Oncology, Biology, Physics|December 20, 2013
Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapiesAlberto Briganti, Steven Joniau, Giorgio Gandaglia, et al.
The Journal of Urology|January 20, 2010
Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissectionMaxine Sun, Giovanni Lughezzani, Ahmed Alasker, et al.
BJU International|November 15, 2011
Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomyThomas F Chromecki, Eugene K Cha, Karl Pummer, et al.
Cancer|June 22, 2011
Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysisShahrokh F Shariat, Caroline Savage, Thomas F Chromecki, et al.
The Journal of Urology|August 13, 2013
Emergency department visits in the United States for upper urinary tract stones: trends in hospitalization and chargesKhurshid R Ghani, Florian Roghmann, Jesse D Sammon, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 17, 2013
Survival after nephroureterectomy for upper tract urothelial carcinoma: a population-based competing-risks analysisGiorgio Gandaglia, Marco Bianchi, Quoc-Dien Trinh, et al.
Clinical Genitourinary Cancer|December 31, 2014
Cardiovascular mortality in patients with metastatic prostate cancer exposed to androgen deprivation therapy: a population-based studyGiorgio Gandaglia, Maxine Sun, Ioana Popa, et al.
Pageof 41